The World Health Organization made waves earlier this year by publishing its first marijuana review. The WHO had lots to say, including a call to place cannabis in a less restrictive schedule of the 1961 United Nations Single Convention on Narcotic Drugs.
Being a former police officer, Lou Haslam knew his family’s story about breaking Australian law to get medicinal cannabis for his son was powerful. It helped lead to a change in the law but, as Gary Nunn reports from Sydney, the family remains unhappy with the result.
Physical and psychological symptom burden in patients with advanced chronic kidney disease (CKD) is significantly debilitating; yet, it is often inadequately treated. Legalization of cannabis in Canada may attract increasing interest from patients for its medical use in refractory symptom management, but its indications and long-term adverse health impacts are poorly established, creating a challenge for clinicians to support its use.
CBD – obtained from cannabis – is the new holy grail of medical science. Hard to treat diseases, chronic ailments and psychological issues are all cured by CBD.
Fibromyalgia is a chronic pain syndrome, characterized by chronic musculoskeletal pain, fatigue, and mood disturbances. There are nearly no data on the effect of medical cannabis (MC) treatment on patients with fibromyalgia. After commencing MC treatment, all the patients reported a significant improvement in every parameter on the questionnaire, and 13 patients (50%) stopped taking any other medications for fibromyalgia. Eight patients (30%) experienced very mild adverse effects.
Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases
Cannabis sativa active compounds are extensively studied for their therapeutic effects, beyond the well-known psychotropic activity. C. Sativa is used to treat different medical indications, such as multiple sclerosis, spasticity, epilepsy, ulcerative colitis and pain. Simultaneously, basic research is discovering new constituents of cannabis-derived compounds and their receptors capable of neuroprotection and neuronal activity modulation.
When I first encountered Anne Mari, Genevieve’s mom, it was by mere chance. In preparation of a long trip to see Compassion patients using cannabis oil the following morning, a cell notification grabbed my attention. Both phones normally have sound turned off -directing a Compassion Alliance providing and re-gifting CBD/Cannabis Oil means both of those phones are continually busy, to this day I still don’t know why I had sound on that night.
As cancer therapies improve, patients are living longer. With these improvements in therapy comes a responsibility to optimize patients’ quality of life during cancer therapy and beyond. This report reviews three timely and important topics. The first section reviews the mechanism underlying chemotherapy-induced peripheral neuropathy and evaluates the evidence for interventions to prevent and treat peripheral neuropathy.
An epileptic teenager’s family are paying thousands of pounds a month for privately prescribed medical cannabis because they cannot get it on the NHS.
On 6 May 2019, Health Europa attended the MJBiz European Cannabis Symposium in Copenhagen, Denmark. At the event, a panel led by Alfredo Pascual (International Analyst for Marijuana Business Daily) discussed the future of Cannabis in Europe, with an Advisor to the Office of the Prime Minister in Malta – John Charles Ellul – taking part.